Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-28 Purchase |
2022-09-29 06:14 am |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC Director 10% Owner |
25,000 | $2.0214 | $50,535 | 4,261,689 (Indirect) |
View |
| 2022-09-28 Purchase |
2022-09-29 06:08 am |
IN8BIO INC. | INAB | Kreis Leslie W. Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner |
25,000 | $2.0214 | $50,535 | 4,261,689 (Indirect) |
View |
| 2022-08-26 Purchase |
2022-08-30 1:16 pm |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner |
51,214 | $2.0178 | $103,340 | 4,258,776 (Indirect) |
View |
| 2022-08-26 Purchase |
2022-08-30 08:10 am |
IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner |
51,214 | $2.0178 | $103,340 | 4,258,776 (Indirect) |
View |
| 2022-08-17 Purchase |
2022-08-18 8:00 pm |
IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner |
50,000 | $1.93 | $96,500 | 4,252,810 (Indirect) |
View |
| 2022-08-17 Purchase |
2022-08-18 7:16 pm |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC Director 10% Owner |
50,000 | $1.93 | $96,500 | 4,252,810 (Indirect) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:17 pm |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Transcend Partners Opportunity Fund LLC Director 10% Owner |
789,473 | $1.9 | $1,499,999 | 4,231,000 (Indirect) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:15 pm |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
26,315 | $1.9 | $49,999 | 2,571,244 (Indirect Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:14 pm |
IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer |
5,263 | $1.9 | $10,000 | 5,263 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:13 pm |
IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer |
5,263 | $1.9 | $10,000 | 5,263 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:11 pm |
IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer |
2,631 | $1.9 | $4,999 | 2,631 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:10 pm |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
526 | $1.9 | $999 | 99,730 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:09 pm |
IN8BIO INC. | INAB | Greenwood Luba Director |
526 | $1.9 | $999 | 7,826 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:08 pm |
IN8BIO INC. | INAB | Roemer Alan S. Director |
26,315 | $1.9 | $49,999 | 55,989 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:07 pm |
IN8BIO INC. | INAB | Brandt Peter C. Director |
105,263 | $1.9 | $200,000 | 287,763 (Indirect Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 10:27 am |
IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund III QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner |
1,773,684 | $1.9 | $3,370,000 | 4,348,150 (Indirect) |
View |
| 2022-08-16 Purchase |
2022-08-17 10:25 am |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC Director 10% Owner |
1,773,684 | $1.9 | $3,370,000 | 4,348,150 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-21 Option Award |
2022-10-25 4:36 pm |
N/A 2032-10-21 |
IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer |
59,796 | $0 | 59,796 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 4:35 pm |
N/A 2032-10-21 |
IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer |
60,555 | $0 | 60,555 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 4:34 pm |
N/A 2032-10-21 |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
62,826 | $0 | 62,826 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 4:33 pm |
N/A 2032-10-21 |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
83,265 | $0 | 83,265 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 4:32 pm |
N/A 2032-10-21 |
IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer |
68,427 | $0 | 68,427 (Direct) |
View |
| 2022-06-01 Option Award(A) |
2022-09-23 5:09 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Whitfill Travis Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2022-06-01 Option Award(A) |
2022-09-23 5:08 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Roemer Alan S. Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2022-06-01 Option Award(A) |
2022-09-23 5:07 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Greenwood Luba Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2022-06-01 Option Award(A) |
2022-09-23 5:06 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Director 10% Owner |
13,500 | $0 | 13,500 (Direct) |
View |
| 2022-06-01 Option Award(A) |
2022-09-23 5:05 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Brandt Peter C. Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-14 7:07 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Brandt Peter C. Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-14 7:05 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Director 10% Owner |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-14 7:03 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Greenwood Luba Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-14 7:02 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Roemer Alan S. Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-14 7:00 pm |
N/A 2032-06-01 |
IN8BIO INC. | INAB | Whitfill Travis Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-09 4:25 pm |
N/A N/A |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
26,204 | $1.0685 | 100,375 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-09 4:25 pm |
N/A 2028-11-11 |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
26,204 | $0 | 100,375 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:41 pm |
N/A 2032-02-15 |
IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer |
84,500 | $0 | 84,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:39 pm |
N/A 2032-02-15 |
IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer |
90,500 | $0 | 90,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:38 pm |
N/A 2032-02-15 |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:37 pm |
N/A 2032-02-15 |
IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer |
96,000 | $0 | 96,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:34 pm |
N/A 2032-02-15 |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
254,500 | $0 | 254,500 (Direct) |
View |
Ownership |
2021-12-10 4:41 pm |
N/A 2030-10-04 |
IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer |
0 | $0 | 123,600 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 4:39 pm |
N/A 2031-11-19 |
IN8BIO INC. | INAB | Roemer Alan S. Director |
86,258 | $0 | 86,258 (Direct) |
View |